The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells

FEBS Letters

Volumn 589, Issue 18, 2015, Pages 2388-2393

  Mercado Pimentel, Melania E ^a,c   Onyeagucha, Benjamin C ^a,b   Li, Qing ^a   Pimentel, Angel C ^b   Jandova, Jana ^a,c   Nelson, Mark A ^a,b,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

AP 1; Colon cancer; Inflammation; Metastasis; microRNAs; miR 21; RAGE; RECK; TCGA

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PROTEIN C FOS; S100 CALCIUM BINDING PROTEIN P; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN RECEPTOR; MICRORNA; MIRN21 MICRORNA, HUMAN; RECK PROTEIN, HUMAN; S100P PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; UPREGULATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MICRORNAS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84938846647     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.07.010     Document Type: Article

References (31)

1. K.R. Sheth, and B.M. Clary Management of hepatic metastases from colorectal cancer Clin. Colon Rectal Surg. 18 2005 215 223
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J. Clin. 60 2010 277 300
3. D. Elias, G. Liberale, D. Vernerey, and et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect Ann. Surg. Oncol. 12 2005 900 909
4. S. Gout, and J. Huot Role of cancer microenvironment in metastasis: focus on colon cancer Cancer Microenviron. 1 2008 69 83
5. J.C. Tse, and R. Kalluri Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment J. Cell. Biochem. 101 2007 816 829
6. S.A. Eccles, and D.R. Welch Metastasis: recent discoveries and novel treatment strategies Lancet 369 2007 1742 1757
7. J. Terzic, S. Grivennikov, E. Karin, and M. Karin Inflammation and colon cancer Gastroenterology 138 2101-14 2010 e5
8. B.C. Onyeagucha, M.E. Mercado-Pimentel, J. Hutchison, E.K. Flemington, and M.A. Nelson S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer Exp. Cell Res. 319 2013 2081 2090
9. A. Chandramouli, M.E. Mercado-Pimentel, A. Hutchinson, and et al. The induction of S100p expression by the Prostaglandin E(2) (PGE(2))/EP4 receptor signaling pathway in colon cancer cells Cancer Biol. Ther. 10 2010 1056 1066
10. M.K. Fuentes, S.S. Nigavekar, T. Arumugam, and et al. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways Dis. Colon Rectum 50 2007 1230 1240
11. T. Arumugam, D.M. Simeone, A.M. Schmidt, and C.D. Logsdon S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) J. Biol. Chem. 279 2004 5059 5065
12. G. Rehbein, A. Simm, H.S. Hofmann, R.E. Silber, and B. Bartling Molecular regulation of S100P in human lung adenocarcinomas Int. J. Mol. Med. 22 2008 69 77
13. Q. Wang, Y.N. Zhang, G.L. Lin, and et al. S100P, a potential novel prognostic marker in colorectal cancer Oncol. Rep. 28 2012 303 310
14. O. Peacock, A.C. Lee, F. Cameron, and et al. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer PLoS One 9 2014 e110267
15. P. Faltejskova, A. Besse, S. Sevcikova, and et al. Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells Int. J. Colorectal Dis. 2012
16. G. Mudduluru, J.N. George-William, S. Muppala, and et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer Biosci. Rep. 31 2011 185 197
17. D. Sayed, S. Rane, J. Lypowy, and et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Mol. Biol. Cell 19 2008 3272 3282
18. J.G. Zhang, J.J. Wang, F. Zhao, Q. Liu, K. Jiang, and G.H. Yang MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) Clin. Chim. Acta 411 2010 846 852
19. A. Chandramouli, B.C. Onyeagucha, M.E. Mercado-Pimentel, and et al. MicroRNA-101 (miR-101) post- transcriptionally regulates the expression of EP4 receptor in colon cancers Cancer Biol. Ther. 13 2012 175 183
20. J.V. Duncia, J.B. Santella 3rd, C.A. Higley, and et al. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products Bioorg. Med. Chem. Lett. 8 1998 2839 2844
21. V.Y. Shin, H. Jin, E.K. Ng, and et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors Carcinogenesis 32 2011 240 245
22. L. Jiang, Y.K. Lai, J. Zhang, and et al. Targeting S100P inhibits colon cancer growth and metastasis by lentivirus-mediated RNA interference and proteomic analysis Mol. Med. 17 2011 709 716
23. Z. Shen, H. Deng, Y. Fang, and et al. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma Oncotarget 2015
24. Y. Teng, B.N. Radde, L.M. Litchfield, and et al. Dehydroepiandrosterone activation of G-protein-coupled estrogen receptor rapidly stimulates microRNA-21 transcription in human hepatocellular carcinoma cells J. Biol. Chem. 290 2015 15799 15811
25. Y. Chen, and S.H. Tseng The potential of RECK inducers as antitumor agents for glioma Anticancer Res. 32 2012 2991 2998
26. S. Kjaer-Frifeldt, T.F. Hansen, B.S. Nielsen, and et al. The prognostic importance of miR-21 in stage II colon cancer: a population-based study Br. J. Cancer 107 2012 1169 1174
27. L. Lu, K. Byrnes, C. Han, Y. Wang, and T. Wu MiR-21 targets 15-PGDH and promotes cholangiocarcinoma growth Mol. Cancer Res. 12 2014 890 900
28. M. Noda, J. Oh, R. Takahashi, S. Kondo, H. Kitayama, and C. Takahashi RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling Cancer Metastasis Rev. 22 2003 167 175
29. J. Oh, R. Takahashi, S. Kondo, and et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis Cell 107 2001 789 800
30. Z. Shi, J. Zhang, X. Qian, and et al. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression Cancer Res. 73 2013 5519 5531
31. M.E. Mercado-Pimentel, A.D. Hubbard, and R.B. Runyan Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation Dev. Biol. 304 2007 420 432